# India Structural Heart Devices Market > India Structural Heart Devices Market Research Report: By Type (Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems), By Indication (Valvular Heart Disease, Cardiomyopathy) andBy Procedure (Replacement Procedures, Repair Procedures) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.62% - **2024:** $ 38.5 Million - **2025:** $ 41.05 Million - **2035:** $ 77.93 Million - **Key Players:** Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Cardinal Health (US), LivaNova (GB), Terumo Corporation (JP), JenaValve Technology (DE), AtriCure (US) **Report ID:** MRFR/HC/55142-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-structural-heart-devices-market-56908 --- ## Market Summary ## **India Structural Heart Devices Market Overview****:** As per MRFR analysis, the India Structural Heart Devices Market Size was estimated at 35.5 (USD Million) in 2024.The India Structural Heart Devices Market Industry is expected to grow from 39.5(USD Million) in 2025 to 95 (USD Million) by 2035. The India Structural Heart Devices Market CAGR (growth rate) is expected to be around 8.305% during the forecast period (2025 - 2035). ### **Key India Structural Heart Devices Market Trends Highlighted** The India Structural Heart Devices Market is experiencing significant growth due to a combination of key market drivers. One of the primary drivers is the increasing prevalence of structural heart diseases, particularly among the aging population. With the Indian government emphasizing healthcare improvements and innovation, there is a push for better management and treatment options for heart diseases.  Furthermore, advancements in technology and medical devices are leading to more effective and less invasive treatment options, thus attracting both healthcare providers and patients alike. Opportunities to be explored include the growing demand for minimally invasive procedures and devices, which becoming a preferred choice for patients and healthcare providers due to shorter recovery times and reduced hospital stays.Additionally, the rising disposable incomes among the urban population in India create a favorable environment for investing in advanced medical technologies, including structural heart devices.  Trends in recent times show a heightened focus on research and development in the Indian healthcare sector, particularly in the field of cardiovascular treatments. This is supported by various government initiatives aimed at boosting healthcare infrastructure and fostering innovation. Collaborations between Indian hospitals and international medical device manufacturers are also on the rise, paving the way for new product introductions tailored to local healthcare needs.With increasing awareness about structural heart diseases and ongoing education for both patients and healthcare professionals, there is a growing recognition of the importance of timely interventions. Overall, the India Structural Heart Devices Market stands poised for significant advancements and expansion in the coming years. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **India Structural Heart Devices Market Drivers** ### **Increasing Cardiovascular Diseases in India** India is experiencing a significant rise in cardiovascular diseases, which is a major driver for the India Structural Heart Devices Market Industry. According to the Indian Heart Association, approximately 30% of deaths in India are attributed to cardiovascular diseases, with an estimated 2 million deaths each year. The prevalence of risk factors such as hypertension, diabetes, and obesity has been escalating in urban areas, leading to a growing demand for structural heart devices.Organizations like the All India Institute of Medical Sciences are actively engaging in Research and Development to improve treatment options, thereby driving investment into this sector. The government's National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke underscores the urgency and financial backing for innovative solutions in the cardiovascular domain, further intensifying the market growth potential. ### **Technological Advancements in Structural Heart Devices** Technological innovations in the design and functionality of structural heart devices are reshaping the India Structural Heart Devices Market Industry. The emergence of minimally invasive procedures has revolutionized patient treatment options, showcasing advancements such as transcatheter aortic valve replacement and percutaneous mitral valve repair. The Indian medical technology landscape is rapidly evolving, with organizations like Medtronic and Boston Scientific investing heavily in Research and Development.Their focus on creating advanced products with improved patient outcomes is vital to market growth. Furthermore, the Indian government has been supportive of technology transfers and collaborations, which enhance access to cutting-edge treatment and expand the market reach for structural heart devices. ### **Growing Geriatric Population** India's demographic trends indicate a rapid increase in the geriatric population, with projections showing that the number of people aged 60 and above will exceed 300 million by 2050 according to the Ministry of Statistics and Programme Implementation. The elderly are more susceptible to heart conditions, creating a significant demand for structural heart devices. This demographic shift has attracted the attention of various healthcare organizations, including the Geriatric Society of India, which advocates for improved healthcare services for older adults.Their efforts to enhance awareness and resources directly stimulate the need for advanced medical devices tailored to the needs of the aging population, thereby bolstering the market. ### **Government Initiatives and Healthcare Policies** The Indian government's focus on enhancing healthcare infrastructure and accessibility significantly influences the India Structural Heart Devices Market Industry. Initiatives such as the Ayushman Bharat scheme aim to provide comprehensive health coverage to more than 500 million individuals. This bolstered healthcare support strengthens the potential for penetration of structural heart devices in both urban and rural settings. Additionally, the government's push for 'Make in India' encourages local manufacturing of medical devices, which aligns with affordable healthcare goals.Advocacy groups such as the Association of Indian Medical Device Industry are seeking better policy constructs that allow innovation while at the same time ensuring product safety and efficacy so as to enhance the market. ## **India Structural Heart Devices Market Segment Insights****:** ### **Structural Heart Devices Market Type Insights** The India Structural Heart Devices Market is characterized by a diverse array of devices that play a critical role in the management of structural heart diseases. This market encompasses various categories such as Heart Valve Devices, Annuloplasty Rings, Occluders, and Delivery Systems, each contributing uniquely to ensuring improved patient outcomes and operational efficiency in healthcare facilities. Heart Valve Devices are crucial as they are increasingly being adopted for minimally invasive procedures, significantly reducing recovery times and surgical risks for patients. Moreover, the growing prevalence of heart diseases in India serves as a significant growth driver for this segment, buoyed by an aging population and lifestyle changes leading to increased cardiovascular risks. Annuloplasty Rings, which support the restoration of heart valve function, have gained traction due to their effectiveness in mitral and tricuspid valve repair, presenting exciting opportunities for surgical advancements in India. As healthcare institutions invest in modernizing their cardiac facilities, these devices are increasingly being utilized to enhance surgical outcomes and streamline procedures. Meanwhile, Occluders, designed for the treatment of conditions such as atrial septal defects, are beneficial in preventing complications associated with abnormal blood flow. They are appreciated for their minimally invasive nature, further fostering their demand amidst rising healthcare awareness among the Indian population. Delivery Systems, essential for the accurate placement of other heart devices, have seen innovations that improve their efficacy, thereby supporting surgical precision. The ongoing advancements in technology, coupled with an increase in healthcare infrastructure, are set to propel the adoption of Structural Heart Devices in India. Market players are focusing on Research and Development to enhance the design and functionality of these devices, further driving the segmentation within the India Structural Heart Devices Market. These factors culminate in a robust environment for growth, shaping the future of heart treatment modalities in India as they aim to meet the evolving needs of patients and healthcare providers alike. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Structural Heart Devices Market Indication Insights** The India Structural Heart Devices Market, particularly in the Indication segment, showcases significant growth and opportunity in areas such as Valvular Heart Disease and Cardiomyopathy. Valvular Heart Disease represents a critical concern in India, influenced by rising cardiovascular issues related to lifestyle and aging demographics, making it an important focus for innovative treatment solutions. Similarly, Cardiomyopathy, which affects the heart muscle's ability to pump blood effectively, accounts for a considerable portion of hospital admissions due to cardiovascular diseases, highlighting the need for advanced therapeutic devices.As Indian healthcare systems evolve, there is a strong demand for minimally invasive procedures that enhance patient outcomes.  This growing awareness about heart health, alongside government initiatives to improve healthcare access, propels the India Structural Heart Devices Market forward, indicating substantial potential for advancements and investments. The market, driven by advancements in technology and rising healthcare needs, is well-poised to meet the challenges posed by these significant cardiovascular conditions, underlining the relevance of investing in these critical areas for improving public health outcomes. ### **Structural Heart Devices Market Procedure Insights** The Procedure segment of the India Structural Heart Devices Market consists mainly of Replacement Procedures and Repair Procedures, both of which are crucial for addressing various cardiovascular diseases prevalent in the population. Replacement Procedures, often required for severe valvular heart diseases, are gaining traction due to the aging population and rising incidences of related health issues, necessitating advanced treatments. Repair Procedures, on the other hand, play a significant role in treating conditions such as mitral regurgitation, where less invasive options are preferred, thereby offering a compelling alternative for patient management. The growing emphasis on minimally invasive techniques further enhances the appeal of these procedures, facilitating quicker recoveries and improved patient outcomes. Moreover, advancements in technology and enhanced skills of healthcare professionals in India contribute to the increasing adoption of these procedures. The segment also faces challenges, including high costs of devices and procedural complexities, but presents ample opportunities for growth driven by increasing healthcare expenditures and better access to healthcare facilities in urban areas.As awareness grows about heart health, the Procedure segment is anticipated to witness a notable transformation, paving the way for innovation and improved patient care in the Structural Heart Devices Market. ## **India Structural Heart Devices Market Key Players and Competitive Insights****:** The India Structural Heart Devices Market has been experiencing significant growth due to an increasing prevalence of cardiovascular diseases and an aging population. Competitive insights into this market reveal a landscape characterized by innovative technological advancements and a focus on minimally invasive procedures. Companies operating in this sector are focusing on enhancing their product portfolios with advanced devices that cater to the specific needs of the Indian healthcare environment.  Key players are engaging in strategic partnerships and collaborations to broaden their market reach and improve patient outcomes. With a growing emphasis on research and development, companies are also investing in developing new technologies aimed at improving the efficiency and safety of heart procedures, which is critical given the rising incidence of heart ailments in India.Cardinal Health has proved to be a formidable player in the India Structural Heart Devices Market through its commitment to quality and innovation.  The company has established a strong presence by offering a wide range of products designed specifically for structural heart diseases. Cardinal Health's strengths lie in its robust distribution network and strong customer relationships, which have facilitated the widespread adoption of its devices in hospitals and clinics across India. Furthermore, the company's continuous focus on training healthcare professionals ensures effective usage of its products, thereby enhancing patient care.  The combination of advanced technology, strategic partnerships, and a deep understanding of the Indian market has allowed Cardinal Health to stand out amid increasing competition.Merit Medical Systems holds a notable position in the India Structural Heart Devices Market, providing various innovative solutions tailored for cardiovascular treatments. The company specializes in a diverse range of products, including those used in transcatheter procedures, guiding catheters, and other vital instruments that play a critical role in structural heart interventions.  Merit Medical Systems benefits from its strategic focus on innovation and the continuous expansion of its product portfolio to meet the evolving needs of the Indian market. The company has also pursued key partnerships and potential mergers to enhance its capabilities and market standing in India. Its dedication to quality and patient safety, coupled with strong relationships with healthcare providers, positions Merit Medical Systems favorably within this competitive landscape. ### **Key Companies in the India Structural Heart Devices Market Include:** - Cardinal Health - Merit Medical Systems - Terumo Corporation - Edwards Lifesciences - Abbott - Alcon - Stryker - Janssen Pharmaceuticals - Corindus Vascular Robotics - Boston Scientific - LivaNova - AtriCure - Medtronic - Glenveigh Medical - Pleura Technologies ## **India Structural Heart Devices Market Industry Developments** _The India Structural Heart Devices Market has seen significant developments recently, with key players like Abbott, Edwards Lifesciences, and Boston Scientific actively expanding their product offerings and market presence. In April 2023, Abbott launched its innovative heart valve device in India aimed at treating structural heart conditions__enhancing patient outcomes. Concurrently, in June 2023, Edwards__Lifesciences announced the acquisition of a local competitor, aligning with the growing demand for minimally invasive procedures in the country. Medtronic and Terumo Corporation have also ramped up investments in Research and Development to innovate more effective devices for cardiac care. _ _The Indian government’s push for advanced healthcare technologies, evidenced by initiatives such as the National Health Mission, is propelling growth in this sector. Furthermore, in the last two years, the rising prevalence of cardiovascular diseases has underscored the urgent need for advanced treatment options, fueling market expansion for companies like Stryker and LivaNova. With an increasing focus on cardiovascular health, coupled with the rapid adoption of healthcare technologies in India, the structural heart devices market is positioned for robust growth, benefiting both healthcare providers and patients alike._ ## **India Structural Heart Devices Market Segmentation Insights** ### **Structural Heart Devices Market Type****Outlook** - Heart Valve Devices - Annuloplasty Rings - Occluders - Delivery Systems ### **Structural Heart Devices Market Indication****Outlook** - Valvular Heart Disease - Cardiomyopathy ### **Structural Heart Devices Market Procedure****Outlook** - Replacement Procedures - Repair Procedures ## Market Drivers ### Rising Geriatric Population The increasing geriatric population in India is a pivotal driver for the structural heart-devices market. As individuals age, the incidence of cardiovascular diseases tends to rise, necessitating advanced medical interventions. By 2025, it is projected that approximately 10% of India's population will be over 60 years old, leading to a heightened demand for structural heart devices. This demographic shift indicates a growing need for innovative solutions to manage age-related heart conditions. Furthermore, the healthcare infrastructure is adapting to cater to this aging population, which may further stimulate market growth. The market is likely to benefit from this trend, as healthcare providers seek to implement effective treatments for elderly patients suffering from various heart ailments. ### Rising Awareness and Education The growing awareness and education regarding cardiovascular health in India are crucial drivers for the structural heart-devices market. Initiatives by healthcare organizations and government bodies aim to educate the public about heart diseases and available treatment options. As awareness increases, patients are more likely to seek medical advice and treatment, leading to a higher demand for structural heart devices. Furthermore, educational campaigns are likely to emphasize the importance of early detection and intervention, which could result in a surge in procedures involving these devices. This heightened awareness may contribute to a more informed patient population, ultimately benefiting the structural heart-devices market. ### Increased Healthcare Expenditure India's rising healthcare expenditure is significantly impacting the structural heart-devices market. With the government and private sectors investing more in healthcare, the overall spending is expected to reach around 3.5% of GDP by 2025. This increase in funding allows for the procurement of advanced medical technologies, including structural heart devices. Hospitals and healthcare facilities are likely to enhance their capabilities, leading to improved patient outcomes. Moreover, as patients become more aware of available treatments, the demand for innovative heart devices is expected to grow. This trend suggests that the structural heart-devices market will experience a positive trajectory, driven by enhanced financial resources allocated to healthcare. ### Government Initiatives and Policies Government initiatives and policies aimed at improving cardiovascular care are likely to bolster the structural heart-devices market. The Indian government has been actively promoting healthcare reforms, including the National Health Mission, which focuses on enhancing access to quality healthcare services. Such initiatives may lead to increased funding for cardiovascular treatments and the adoption of advanced technologies. Additionally, regulatory support for the approval of new devices can expedite their entry into the market. This supportive environment may encourage manufacturers to invest in research and development, ultimately benefiting the structural heart-devices market by providing a wider array of treatment options for patients. ### Technological Innovations in Healthcare Technological innovations in healthcare are transforming the landscape of the structural heart-devices market. Advancements in minimally invasive procedures and device design are enhancing the efficacy and safety of treatments. For instance, the introduction of transcatheter aortic valve replacement (TAVR) has revolutionized the management of aortic stenosis, providing patients with less invasive options. As these technologies continue to evolve, they are likely to attract more patients seeking effective solutions for heart conditions. The structural heart-devices market is expected to thrive as healthcare providers adopt these innovations, leading to improved patient outcomes and increased procedural volumes. ## Future Outlook The [Structural Heart Devices Market](https://www.marketresearchfuture.com/reports/structural-heart-devices-market-6385) in India is projected to grow at a 6.62% CAGR from 2025 to 2035, driven by technological advancements and increasing prevalence of heart diseases. **New opportunities:** - Development of minimally invasive surgical techniques for heart valve repair. - Expansion of telehealth services for remote patient monitoring and follow-up. - Investment in R&D for innovative biomaterials in device manufacturing. By 2035, the market is expected to achieve substantial growth, driven by innovation and increasing healthcare demands. ## Segment Insights ### By Type: Transcatheter Aortic Valve Replacement (Largest) vs. Mitral Valve Repair Devices (Fastest-Growing) The India structural heart-devices market shows a diverse distribution of market shares among its various segments. Transcatheter Aortic Valve Replacement (TAVR) leads this sector, capturing a significant share due to its established presence and widely recognized benefits. Following closely are Mitral Valve Repair Devices, Left Atrial Appendage Closure Devices, and Transcatheter Pulmonary Valve technologies, each playing vital roles in the overall landscape but with varying market spreads. Growth trends indicate a robust advance particularly for Mitral Valve Repair Devices, which are emerging rapidly due to technological advancements and increasing awareness among healthcare professionals and patients alike. The overall market is driven by an aging population, rising prevalence of heart diseases, and an increasing preference for minimally invasive procedures, solidifying the future outlook for these segments. Mitral Valve Repair Devices (Dominant) vs. Left Atrial Appendage Closure Devices (Emerging) Mitral Valve Repair Devices stand out as a dominant force in the India structural heart-devices market, owing to their effectiveness in treating mitral valve conditions that are prevalent among older populations. These devices are characterized by their capability to minimize surgical risks and facilitate faster recovery times, which appeals to both patients and clinicians. On the other hand, Left Atrial Appendage Closure Devices are emerging as a critical solution for patients at risk of stroke due to atrial fibrillation. Their adoption is gaining momentum as they provide an effective and safe option, further expanding their footprint in the market as innovative technologies continue to develop. The contrasting dynamics between these two segments highlight the evolving nature of the market. ### By Procedure Type: Minimally Invasive (Largest) vs. Surgical (Fastest-Growing) The market distribution among the procedure types in the India structural heart-devices market shows a significant preference for Minimally Invasive techniques, which hold the largest share due to their advanced technologies and patient outcomes. Surgical methods, while traditionally prevalent, are gradually declining in preference as patients and healthcare providers increasingly opt for less invasive options. In terms of growth trends, Minimally Invasive techniques are expected to remain dominant, driven by the rising adoption of new technologies and increasing patient awareness. Conversely, Surgical techniques are evolving, with innovations aimed at improving safety and recovery times, contributing to their designation as the fastest-growing segment. The growth is fueled by an increasing number of clinical trials and the introduction of novel surgical devices that enhance procedural efficacy. Minimally Invasive (Dominant) vs. Surgical (Emerging) Minimally Invasive procedures are gaining traction in the India structural heart-devices market, renowned for their benefits such as reduced recovery times and decreased hospital stays. They encompass technologies like transcatheter aortic valve replacement (TAVR) and percutaneous interventions, which are redefining patient management. On the other hand, Surgical approaches are emerging, focusing on hybrid techniques that combine traditional methods with less invasive strategies, thereby retaining their relevance. While Minimally Invasive remains dominant, the surgical segment is experiencing technological enhancements aimed at improving procedural accuracy and minimizing complications, making it an important player in the overall market. ### By Indication: Aortic Stenosis (Largest) vs. Mitral Regurgitation (Fastest-Growing) In the India structural heart-devices market, Aortic Stenosis emerges as the largest segment, commanding a significant share due to the high prevalence of this condition among the aging population. Mitral Regurgitation follows closely, showcasing a strong growth trajectory as awareness and diagnosis improve, leading to increased demand for innovative treatment options. Growth trends in the segment are driven by advancements in technology and increasing investment in healthcare infrastructure. Aortic Stenosis treatment options are expanding, bolstered by strong clinical evidence and patient outcomes. Meanwhile, Mitral Regurgitation is gaining traction as a range of minimally invasive procedures are developed, appealing to both patients and clinicians seeking effective solutions with reduced recovery times. Aortic Stenosis (Dominant) vs. Mitral Regurgitation (Emerging) Aortic Stenosis represents the dominant force in the India structural heart-devices market, primarily characterized by traditional surgical interventions and transcatheter aortic valve replacements (TAVR), which have become standard treatment protocols. This segment benefits from well-established diagnostic and treatment pathways, ensuring high patient turnover and consistent demand. In contrast, Mitral Regurgitation is positioned as an emerging segment, reflecting increased awareness and innovations in catheter-based therapies. The emergence of novel devices and techniques offers less invasive alternatives to surgery, fostering a growing market interest as healthcare providers transition towards more patient-centered approaches. ### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing) In the India structural heart-devices market, hospitals dominate the end user segment, capturing the majority of market share due to their extensive infrastructure, access to advanced technologies, and a higher patient volume for complex procedures. Ambulatory surgical centers follow as a growing force, attracting a significant share of patients seeking minimally invasive procedures and cost-effective treatments while reducing hospital stays. Growth trends indicate that ambulatory surgical centers are the fastest-growing segment, driven by an increasing preference for outpatient care and advancements in surgical technologies. Technological innovations and changing demographics, such as a rising number of cardiovascular ailments and an aging population, contribute to this growth. As patients increasingly opt for procedures that allow them to return home the same day, the demand for services offered by ambulatory surgical centers is expected to rise substantially. Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging) Hospitals represent the dominant force in the end user segment, primarily because they provide comprehensive services that cater to a wide range of complex cardiovascular procedures. They are equipped with advanced infrastructure, skilled cardiology specialists, and supportive health services, making them the preferred choice for many patients. On the other hand, ambulatory surgical centers are emerging as a competitive option, focusing on efficiency and patient convenience. These centers appeal to patients who prefer quick, outpatient interventions, often resulting in lower costs and shorter recovery times. The shift towards more outpatient solutions marks a significant transformation in patient preferences, driving both segments to adapt and innovate in response to changing needs. ## Competitive Benchmarking The structural heart-devices market in India is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Major players such as Edwards Lifesciences (US), Medtronic (US), and Abbott Laboratories (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. Edwards Lifesciences (US) emphasizes its commitment to research and development, particularly in transcatheter heart valve technologies, while Medtronic (US) is leveraging its extensive portfolio to expand its reach in minimally invasive procedures. Abbott Laboratories (US) is also investing heavily in digital health solutions, indicating a trend towards integrating technology with traditional medical devices, thereby shaping a competitive environment that prioritizes innovation and patient outcomes.The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing. This approach not only reduces operational costs but also enhances responsiveness to market demands. The competitive structure of the market appears moderately fragmented, with several key players vying for market share. However, the collective influence of these major companies is significant, as they set industry standards and drive advancements in product offerings. In October Medtronic (US) announced the launch of its latest transcatheter aortic valve replacement (TAVR) system, which is designed to improve patient outcomes through enhanced delivery mechanisms. This strategic move is likely to solidify Medtronic's position in the market, as it addresses the growing demand for less invasive cardiac procedures. The introduction of this innovative product aligns with the company's broader strategy of focusing on patient-centric solutions, which may enhance its competitive edge. In September Abbott Laboratories (US) expanded its partnership with a leading Indian healthcare provider to enhance access to its structural heart devices across the country. This collaboration is indicative of Abbott's strategy to penetrate deeper into the Indian market, ensuring that its advanced technologies are accessible to a larger patient population. Such partnerships are crucial in a market where localized strategies can significantly impact adoption rates and overall market growth. In August Edwards Lifesciences (US) entered into a joint venture with a prominent Indian medical device manufacturer to co-develop innovative heart valve solutions tailored for the local market. This strategic alliance not only facilitates knowledge transfer but also positions Edwards Lifesciences to better understand and meet the specific needs of Indian patients, thereby enhancing its competitive positioning. As of November the competitive trends in the structural heart-devices market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into product development. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, reliability in supply chains, and the ability to deliver superior patient outcomes. This shift underscores the importance of innovation and strategic partnerships in navigating the complexities of the market. ## Recent News & Developments _The India Structural Heart Devices Market has seen significant developments recently, with key players like Abbott, Edwards Lifesciences, and Boston Scientific actively expanding their product offerings and market presence. In April 2023, Abbott launched its innovative heart valve device in India aimed at treating structural heart conditions__enhancing patient outcomes. Concurrently, in June 2023, Edwards__Lifesciences announced the acquisition of a local competitor, aligning with the growing demand for minimally invasive procedures in the country. Medtronic and Terumo Corporation have also ramped up investments in Research and Development to innovate more effective devices for cardiac care. _ _The Indian government’s push for advanced healthcare technologies, evidenced by initiatives such as the National Health Mission, is propelling growth in this sector. Furthermore, in the last two years, the rising prevalence of cardiovascular diseases has underscored the urgent need for advanced treatment options, fueling market expansion for companies like Stryker and LivaNova. With an increasing focus on cardiovascular health, coupled with the rapid adoption of healthcare technologies in India, the structural heart devices market is positioned for robust growth, benefiting both healthcare providers and patients alike._ ## Report Scope | MARKET SIZE 2024 | 38.5(USD Million) | | --- | --- | | MARKET SIZE 2025 | 41.05(USD Million) | | MARKET SIZE 2035 | 77.93(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.62% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Cardinal Health (US), LivaNova (GB), Terumo Corporation (JP), JenaValve Technology (DE), AtriCure (US) | | Segments Covered | Type, Procedure Type, Indication, End User | | Key Market Opportunities | Advancements in minimally invasive procedures enhance growth potential in the structural heart-devices market. | | Key Market Dynamics | Rising demand for minimally invasive procedures drives innovation in structural heart-devices within the Indian market. | | Countries Covered | India | ## Frequently Asked Questions **Q: What is the current valuation of the India structural heart-devices market?** A: The market valuation was $38.5 Million in 2024. **Q: What is the projected market size for the India structural heart-devices market by 2035?** A: The market is expected to reach $77.93 Million by 2035. **Q: What is the expected CAGR for the India structural heart-devices market during the forecast period 2025 - 2035?** A: The expected CAGR is 6.62% from 2025 to 2035. **Q: Which companies are the key players in the India structural heart-devices market?** A: Key players include Edwards Lifesciences, Medtronic, Abbott Laboratories, and Boston Scientific. **Q: What are the main segments of the India structural heart-devices market?** A: The main segments include Type, Procedure Type, Indication, and End User. **Q: What was the market size for Transcatheter Aortic Valve Replacement in 2024?** A: The market size for Transcatheter Aortic Valve Replacement was $15.4 Million in 2024. **Q: How much is the Mitral Valve Repair Devices segment projected to grow by 2035?** A: The Mitral Valve Repair Devices segment is projected to grow to $20.0 Million by 2035. **Q: What is the market size for Left Atrial Appendage Closure Devices in 2024?** A: The market size for Left Atrial Appendage Closure Devices was $7.5 Million in 2024. **Q: Which end user segment had the highest valuation in 2024?** A: Hospitals had the highest valuation at $15.4 Million in 2024. **Q: What is the projected market size for Pulmonary Valve Stenosis by 2035?** A: The market size for Pulmonary Valve Stenosis is projected to reach $17.93 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-structural-heart-devices-market-56908*